The effective shelf creates a standing overhang of ~1.95M shares that selling stockholders can unload at any time. Monitor for a takedown notice (424B5) or insider selling volume spikes. The low dollar amount relative to market cap suggests limited immediate pressure, but the stock's low liquidity could amplify any selling. No catalyst or pipeline update is bundled with this filing.
LYEL drugs
LYEL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 22 $12.84entry
- T+1 · 4mo ago −0.47%α +0.77% · $12.78
- T+5 · 4mo ago +1.01%α +3.41% · $12.97
- T+20 · 3mo ago +22.74%α +19.84% · $15.76
- T+60 · 5w ago −36.22%α −39.48% · $8.19
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Lyell Immunopharma's S-3 shelf registration (File No. 333-297433) became effective on July 21, 2026. This allows selling stockholders to resell up to 1,952,360 shares of common stock acquired in a March 2026 private placement. The company receives no proceeds from these sales, but the effectiveness introduces a potential overhang of ~1.95M shares that can be sold into the market at any time, representing approximately 0.6% of the current market cap of $321M, a modest but real dilution risk for a pre-revenue biotech with limited liquidity.
Key Facts
- S-3 shelf registration (File No. 333-297433) became effective on July 21, 2026.
- Registration covers resale of 1,952,360 shares of common stock by selling stockholders.
- Selling stockholders include institutional investors ARCH Venture Fund, Gates Frontier, and Explore Investments.
- Lyell Immunopharma will not receive any proceeds from these share sales.
- Shares were originally purchased at $25.61 per share in a March 6, 2026 private placement.
- Current market cap is $321M; the registered shares represent ~0.6% of outstanding shares.
Financial Impact
Potential overhang of ~1.95M shares (~0.6% of market cap at $321M) that can be sold at any time; no proceeds to the company.
Risk Factors
- Selling stockholders may begin selling shares immediately, creating downward price pressure.
- Low trading liquidity could amplify the impact of any share sales.
- No company proceeds from sales, the overhang provides no operational benefit to offset dilution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002375 |
| Document: 9999999995-26-002375-index.html | 9999999995-26-002375 |
| Document: 9999999995-26-002375.txt | 9999999995-26-002375 |
Track record
21 reports on LYEL
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +17.99% at T+60 after the Jun 8, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 13, 20263d ago S-3 Neutral 3/10 Entry $14.30 Now $14.65 +2.45% settles Nov 17
- Nov 12, 20264d ago Insider Cluster Bullish 6/10 Entry $14.30 to $14.65 Now $14.65 +2.45% ▲ +2.45% +4.36% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $16.86 to $15.64 Now $14.65 −13.11% ▼ −7.24% −6.88% vs SPY
- Nov 5, 202611d ago Insider Cluster Bullish 7/10 Entry $14.86 to $15.42 Now $14.65 −1.41% ▲ +3.77% +1.40% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.00 to $14.86 Now $14.65 −2.33% ▼ −0.93% −1.25% vs SPY
- Nov 4, 202612d ago 8-K Bearish 5/10 Entry $15.43 to $15.00 Now $14.65 +5.06% ▲ +2.79% −1.62% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.43 to $15.00 Now $14.65 −5.06% ▼ −2.79% +1.62% vs SPY
- Aug 25, 202611w ago Insider Cluster Neutral 4/10 Entry $14.80 to $14.61 Now $14.65 −1.01% ▼ −1.28% −1.94% vs SPY
- Jul 22, 202616w ago EFFECT Neutral 4/10 Viewing Entry $12.84 to $12.78 Now $14.65 +14.10% ▼ −0.47% +0.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers